IGF1 and neoplasm: The MSCs in the hypoxic tumour microenvironment produced leptin, which is capable of inducing erlotinib resistance in lung adenocarcinoma cells through the activation of IGF-R1 signalling in the absence of IGF-1 in hypoxia.